Skip NavigationSkip to Content

Efavirenz Induces CYP2B6-Mediated Hydroxylation of Bupropion in Healthy Subjects

  1. Author:
    Robertson, S. M.
    Maldarelli, F.
    Natarajan, V.
    Formentini, E.
    Alfaro, R. M.
    Penzak, S. R.
  2. Author Address

    Robertson, Sarah M.] US FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA. [Maldarelli, Frank] Natl Canc Inst, HIV Drug Resistance Program, Frederick, MD USA. [Natarajan, Ven] Natl Canc Inst, SAIC Frederick, Mol Cell Biol Lab, Frederick, MD USA. [Formentini, Elizabeth] NIH, Dept Crit Care Med, Bethesda, MD 20892 USA. [Alfaro, Raul M.; Penzak, Scott R.] NIH, Clin Res Ctr, Dept Pharm, Bethesda, MD 20892 USA.
    1. Year: 2008
  1. Journal: Jaids-Journal of Acquired Immune Deficiency Syndromes
    1. 49
    2. 5
    3. Pages: 513-519
  2. Type of Article: Article
  1. Abstract:

    Objective: To characterize the effect of efavirenz on bupropion hydroxylation as a marker of cytochrome P450 (CYP) 2136 activity in healthy subjects. Methods: Thirteen subjects received a single oral dose of bupropion SR 150 mg before and after 2 weeks of efavirenz administration for comparison of bupropion and hydroxybupropion pharmacokinetics. Efavirenz plasma concentrations were also assessed. Subjects were genotyped for CYP2B6 (G516T, C1459T, and A785G), CYP3A4 (A-392G), CYP3A5 (A6986G), and multidrug resistance protein 1 (C3435T). Results: The area under the concentration vs. time curve ratio of hydroxybupropion: bupropion increased 2.3-fold after efavirenz administration (P = 0.0001). Bupropion area under the concentration vs. time curve and C-max decreased by 55% and 34%, respectively (P < 0.002). None of the CYP2B6 or CYP3A genotypes evaluated were associated with a difference in bupropion or efavirenz clearance. The 2 individuals homozygous for multidrug resistance protein 1 3435-T/T had 2.5- and 1.8-fold greater bupropion and efavirenz clearance, respectively, relative to C/C and C/T individuals (P < 0.05). Conclusions: Our results confirm that efavirenz induces CYP2B6 enzyme activity in vivo, as demonstrated by an increase in bupropion hydroxylation after 2 weeks of efavirenz administration.

    See More

External Sources

  1. PMID: 18989234

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel